The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 02, 2024

Filed:

Oct. 13, 2020
Applicant:

Immunewalk Therapeutics, Inc., Pearl River, NY (US);

Inventors:

Itzhak Mendel, Rehovot, IL;

Oshrat Propheta-Meiran, Petah Tikva, IL;

Yaniv Salem, Kyriat Ono, IL;

Anat Shoham, Hod Hasharon, IL;

Niva Yacov, Tel Aviv, IL;

Eyal Breitbart, Hashmonaim, IL;

Assignee:

ImmuneWalk Therapeutics, Inc., Pearl River, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/30 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); C07K 16/18 (2006.01); C12Q 1/6886 (2018.01); G01N 33/50 (2006.01); G01N 33/574 (2006.01); G01N 33/68 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); C07K 14/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/30 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 16/18 (2013.01); C12Q 1/6886 (2013.01); G01N 33/5017 (2013.01); G01N 33/5029 (2013.01); G01N 33/574 (2013.01); G01N 33/57492 (2013.01); G01N 33/689 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); C07K 14/00 (2013.01); C07K 2317/21 (2013.01); C07K 2317/54 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/435 (2013.01);
Abstract

Disclosed herein are methods of treating, reducing the incidence of, or preventing one or more activities in or of a cancer cell, methods of treating, reducing the incidence of, or preventing migration or metastasis of a cancer cell, methods of treating, reducing the incidence of, or preventing a cancer by reducing tumor associated macrophages (TAMs) or their migration, and methods of treating, reducing the incidence of, or preventing a cancer (including metastatic cancer), for example, with an inhibitor of Motile Sperm Domain containing Protein 2 (MOSPD2). Also disclosed are inhibitors of MOSPD2 (e.g., anti-MOSPD2 antibodies or antigen binding fragments thereof) and pharmaceutical compositions containing MOSPD2 inhibitors. Also disclosed are methods for the prediction, diagnosis, or prognosis of cancer, cancer metastasis, tumor progression, or tumor invasiveness in a subject.


Find Patent Forward Citations

Loading…